PGF and breast cancer: These trends were particularly contrasting in the plasma profile since all the markers quantified in plasma i.e. NRP-1, VEGF, TGFβ1 and PlGF indicated opposing trends in early onset breast cancer vs older cases, with comparable variability in both healthy controls and breast cancer cases.